These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Capillary column GLC-mass spectrometric assay with selected-ion monitoring for timolol and [13C3]timolol in human plasma. Carlin JR; Walker RW; Davies RO; Ferguson RT; Vandenheuvel WJ J Pharm Sci; 1980 Oct; 69(10):1111-5. PubMed ID: 7420275 [TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals. Ishizaki T; Tawara K; Oyama Y; Nakaya H J Clin Pharmacol; 1978; 18(11-12):511-8. PubMed ID: 721948 [TBL] [Abstract][Full Text] [Related]
8. Plasma timolol levels after oral and intravenous administration. Else OF; Sorenson H; Edwards IR Eur J Clin Pharmacol; 1978 Dec; 14(6):431-4. PubMed ID: 738350 [TBL] [Abstract][Full Text] [Related]
9. The disposition of timolol in man. Vermeij P; el-Sherbini-Schepers M; van Zwieten PA J Pharm Pharmacol; 1978 Jan; 30(1):53-5. PubMed ID: 22728 [No Abstract] [Full Text] [Related]
10. Pharmacokinetic differences between single and multiple oral dosing with the guidance for beta-adrenoceptor blockade assessment. Ishizaki T; Tawara K Cardiology; 1979; 64 Suppl 1():25-43. PubMed ID: 42487 [TBL] [Abstract][Full Text] [Related]
11. Estimation of the systemic bioavailability of timolol in man. El-Rashidy R Biopharm Drug Dispos; 1981; 2(2):197-202. PubMed ID: 7248483 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers. Vedin JA; Kristianson JK; Wilhelmsson CE Eur J Clin Pharmacol; 1982; 23(1):43-7. PubMed ID: 7128671 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent. Ishizaki T; Ohnishi A; Sasaki T; Kushida K; Horai Y; Chiba K; Suganuma T Eur J Clin Pharmacol; 1983; 25(1):95-101. PubMed ID: 6137389 [TBL] [Abstract][Full Text] [Related]
15. Physiological disposition and metabolism of timolol in man and laboratory animals. Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617 [TBL] [Abstract][Full Text] [Related]
16. The use of stable isotope labeling and liquid chromatography-tandem mass spectrometry techniques to simultaneously determine the oral and ophthalmic bioavailability of timolol in dogs. Gilbert JD; Olah TV; Morris MJ; Bortnick A; Brunner J J Chromatogr Sci; 1998 Apr; 36(4):163-8. PubMed ID: 9563202 [TBL] [Abstract][Full Text] [Related]
17. Kinetics and absolute bioavailability of atenolol. Mason WD; Winer N; Kochak G; Cohen I; Bell R Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185 [TBL] [Abstract][Full Text] [Related]
18. [The bioavailability of transdermal therapeutic system of timolol]. Ji XF; Ping QN; Liu GJ; Yu ST Yao Xue Xue Bao; 1993; 28(8):609-13. PubMed ID: 8285070 [TBL] [Abstract][Full Text] [Related]
19. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. Jufer RA; Wstadik A; Walsh SL; Levine BS; Cone EJ J Anal Toxicol; 2000 Oct; 24(7):467-77. PubMed ID: 11043648 [TBL] [Abstract][Full Text] [Related]
20. Active transport of beta-adrenergic blocking agents in the anterior uvea of albino rabbit. Matsumoto S; Araie M; Takase M Jpn J Ophthalmol; 1986; 30(4):339-50. PubMed ID: 2884338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]